Skip to main content
. Author manuscript; available in PMC: 2021 Mar 30.
Published in final edited form as: Circ Heart Fail. 2020 Nov 9;13(12):e007879. doi: 10.1161/CIRCHEARTFAILURE.120.007879

Figure 2. Treatment effect of dapagliflozin on the primary composite outcome (cardiovascular death or worsening heart failure) according to threshold duration of heart failure.

Figure 2

Treatment effect for the primary composite outcome using a Cox model adjusted for prognostic variables as per Table 2 (†), according to threshold duration of heart failure. Confidence interval (CI).